Stocks and Investing Stocks and Investing
Thu, January 25, 2018

Michael Weinstein Maintained (ABT) at Buy with Increased Target to $69 on, Jan 25th, 2018


Published on 2024-10-26 02:10:41 - WOPRAI, Michael Weinstein
  Print publication without navigation


Michael Weinstein of JP Morgan, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $65 to $69 on, Jan 25th, 2018.

Michael has made no other calls on ABT in the last 4 months.



There are 3 other peers that have a rating on ABT. Out of the 3 peers that are also analyzing ABT, 2 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Sean Lavin of "BTIG" Downgraded from Strong Buy to Hold on, Monday, January 22nd, 2018
  • Amit Hazan of "Citigroup" Maintained at Hold with Increased Target to $59 on, Thursday, October 19th, 2017


This is the rating of the analyst that currently disagrees with Michael


  • Vijay Kumar of "Evercore ISI Group" Initiated at Buy and Held Target at $64 on, Wednesday, January 3rd, 2018

Contributing Sources